# A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

> **NCT00651807** · PHASE2 · TERMINATED · sponsor: **Organon and Co** · enrollment: 16 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DRUG:** etonogestrel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00651807
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Business Reasons
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651807, "A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00651807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*